BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 31846068)

  • 1. Pharmacological interventions for treatment-resistant depression in adults.
    Davies P; Ijaz S; Williams CJ; Kessler D; Lewis G; Wiles N
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD010557. PubMed ID: 31846068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological therapies for treatment-resistant depression in adults.
    Ijaz S; Davies P; Williams CJ; Kessler D; Lewis G; Wiles N
    Cochrane Database Syst Rev; 2018 May; 5(5):CD010558. PubMed ID: 29761488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressants plus benzodiazepines for adults with major depression.
    Ogawa Y; Takeshima N; Hayasaka Y; Tajika A; Watanabe N; Streiner D; Furukawa TA
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD001026. PubMed ID: 31158298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatment for psychotic depression.
    Kruizinga J; Liemburg E; Burger H; Cipriani A; Geddes J; Robertson L; Vogelaar B; Nolen WA
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD004044. PubMed ID: 34875106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vortioxetine for depression in adults.
    Koesters M; Ostuzzi G; Guaiana G; Breilmann J; Barbui C
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011520. PubMed ID: 28677828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressants for depression in adults with HIV infection.
    Eshun-Wilson I; Siegfried N; Akena DH; Stein DJ; Obuku EA; Joska JA
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD008525. PubMed ID: 29355886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological interventions for somatoform disorders in adults.
    Kleinstäuber M; Witthöft M; Steffanowski A; van Marwijk H; Hiller W; Lambert MJ
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010628. PubMed ID: 25379990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
    Pollok J; van Agteren JE; Carson-Chahhoud KV
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressants for the treatment of people with co-occurring depression and alcohol dependence.
    Agabio R; Trogu E; Pani PP
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008581. PubMed ID: 29688573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-adenosyl methionine (SAMe) for depression in adults.
    Galizia I; Oldani L; Macritchie K; Amari E; Dougall D; Jones TN; Lam RW; Massei GJ; Yatham LN; Young AH
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD011286. PubMed ID: 27727432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults.
    Machmutow K; Meister R; Jansen A; Kriston L; Watzke B; Härter MC; Liebherz S
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012855. PubMed ID: 31106850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acupuncture for depression.
    Smith CA; Armour M; Lee MS; Wang LQ; Hay PJ
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD004046. PubMed ID: 29502347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological interventions for the treatment of disordered and problem gambling.
    Dowling N; Merkouris S; Lubman D; Thomas S; Bowden-Jones H; Cowlishaw S
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD008936. PubMed ID: 36130734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mirtazapine adjunct for people with schizophrenia.
    Perry LA; Ramson D; Stricklin S
    Cochrane Database Syst Rev; 2018 May; 5(5):CD011943. PubMed ID: 29802811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial interventions for preventing and treating depression in dialysis patients.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Rabindranath KS; Strippoli GF
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004542. PubMed ID: 31789430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.
    Edwards SJ; Hamilton V; Nherera L; Trevor N
    Health Technol Assess; 2013 Nov; 17(54):1-190. PubMed ID: 24284258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
    Barber S; Olotu U; Corsi M; Cipriani A
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006324. PubMed ID: 28333365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries.
    Mishu MP; Uphoff E; Aslam F; Philip S; Wright J; Tirbhowan N; Ajjan RA; Al Azdi Z; Stubbs B; Churchill R; Siddiqi N
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013281. PubMed ID: 33591592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.